Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Renal Insufficiency, Chronic | 54 | 2023 | 2208 | 3.750 |
Why?
|
Kidney Failure, Chronic | 33 | 2023 | 2538 | 3.230 |
Why?
|
Renal Dialysis | 18 | 2023 | 1786 | 2.710 |
Why?
|
Diabetic Nephropathies | 14 | 2023 | 984 | 2.380 |
Why?
|
Kidney Transplantation | 19 | 2023 | 4251 | 2.280 |
Why?
|
Calcinosis | 9 | 2013 | 1499 | 1.710 |
Why?
|
Coronary Artery Disease | 12 | 2022 | 6487 | 1.160 |
Why?
|
Erectile Dysfunction | 4 | 2021 | 461 | 1.050 |
Why?
|
Glomerular Filtration Rate | 29 | 2023 | 2170 | 0.990 |
Why?
|
Nephrology | 4 | 2023 | 263 | 0.940 |
Why?
|
Kidney Diseases | 11 | 2023 | 2149 | 0.790 |
Why?
|
Renal Replacement Therapy | 2 | 2021 | 257 | 0.660 |
Why?
|
Kidney | 17 | 2024 | 7186 | 0.650 |
Why?
|
Cardiovascular Diseases | 22 | 2024 | 15165 | 0.620 |
Why?
|
Interleukin-6 | 5 | 2022 | 3200 | 0.600 |
Why?
|
Diabetes Mellitus | 8 | 2022 | 5751 | 0.570 |
Why?
|
Lipoprotein(a) | 3 | 2007 | 435 | 0.530 |
Why?
|
Arteriovenous Shunt, Surgical | 3 | 2017 | 277 | 0.490 |
Why?
|
Fibroblast Growth Factors | 4 | 2016 | 879 | 0.460 |
Why?
|
Albuminuria | 9 | 2022 | 682 | 0.450 |
Why?
|
Disease Progression | 21 | 2022 | 13284 | 0.430 |
Why?
|
Coronary Vessels | 4 | 2014 | 3107 | 0.420 |
Why?
|
Health Literacy | 3 | 2014 | 414 | 0.420 |
Why?
|
C-Reactive Protein | 4 | 2021 | 3778 | 0.420 |
Why?
|
Heart Valves | 1 | 2013 | 291 | 0.400 |
Why?
|
Diabetes Mellitus, Type 2 | 11 | 2023 | 11725 | 0.390 |
Why?
|
Catheters, Indwelling | 2 | 2012 | 426 | 0.390 |
Why?
|
Polytetrafluoroethylene | 1 | 2012 | 233 | 0.380 |
Why?
|
Diabetes Mellitus, Type 1 | 6 | 2023 | 3336 | 0.380 |
Why?
|
Graft Survival | 5 | 2023 | 3737 | 0.360 |
Why?
|
Humans | 125 | 2024 | 744343 | 0.350 |
Why?
|
Middle Aged | 67 | 2022 | 213383 | 0.330 |
Why?
|
Hypertriglyceridemia | 2 | 2003 | 293 | 0.320 |
Why?
|
Allopurinol | 2 | 2020 | 191 | 0.320 |
Why?
|
United States Government Agencies | 1 | 2008 | 26 | 0.320 |
Why?
|
Cohort Studies | 31 | 2022 | 40561 | 0.320 |
Why?
|
Prospective Studies | 32 | 2022 | 53288 | 0.300 |
Why?
|
Adult | 58 | 2023 | 214055 | 0.300 |
Why?
|
Tunica Intima | 1 | 2009 | 464 | 0.300 |
Why?
|
Renal Insufficiency | 3 | 2023 | 804 | 0.290 |
Why?
|
Blood Pressure | 5 | 2021 | 8554 | 0.290 |
Why?
|
Minority Health | 1 | 2008 | 87 | 0.290 |
Why?
|
Male | 74 | 2024 | 350118 | 0.290 |
Why?
|
Cholesterol, HDL | 3 | 2014 | 1814 | 0.270 |
Why?
|
Uric Acid | 3 | 2022 | 766 | 0.270 |
Why?
|
Glaucoma | 1 | 2015 | 1159 | 0.270 |
Why?
|
Kidney Function Tests | 7 | 2022 | 684 | 0.260 |
Why?
|
Heart Valve Diseases | 1 | 2013 | 1073 | 0.260 |
Why?
|
Aorta | 2 | 2011 | 2061 | 0.260 |
Why?
|
Carotid Stenosis | 1 | 2012 | 854 | 0.260 |
Why?
|
Cystatin C | 3 | 2023 | 250 | 0.250 |
Why?
|
Carotid Arteries | 1 | 2009 | 952 | 0.250 |
Why?
|
Renin-Angiotensin System | 5 | 2020 | 759 | 0.250 |
Why?
|
Female | 70 | 2024 | 380194 | 0.250 |
Why?
|
Health Priorities | 1 | 2008 | 380 | 0.250 |
Why?
|
Atherosclerosis | 4 | 2024 | 3445 | 0.240 |
Why?
|
Aged | 50 | 2024 | 163280 | 0.240 |
Why?
|
Risk Factors | 32 | 2024 | 72290 | 0.240 |
Why?
|
Proteinuria | 3 | 2019 | 658 | 0.240 |
Why?
|
Hyperglycemia | 2 | 2022 | 1373 | 0.230 |
Why?
|
Coronary Disease | 3 | 2014 | 6077 | 0.230 |
Why?
|
Efficiency, Organizational | 1 | 2008 | 695 | 0.220 |
Why?
|
Sleep Apnea Syndromes | 1 | 2011 | 944 | 0.220 |
Why?
|
Lipocalins | 2 | 2014 | 170 | 0.220 |
Why?
|
Aortic Diseases | 1 | 2009 | 742 | 0.220 |
Why?
|
Acute-Phase Proteins | 2 | 2014 | 262 | 0.210 |
Why?
|
Myocardial Infarction | 7 | 2021 | 11727 | 0.210 |
Why?
|
Health Policy | 2 | 2021 | 2661 | 0.210 |
Why?
|
Resistin | 1 | 2022 | 170 | 0.200 |
Why?
|
Peripheral Arterial Disease | 3 | 2021 | 1188 | 0.200 |
Why?
|
Prevalence | 9 | 2020 | 15226 | 0.200 |
Why?
|
Organ Transplantation | 2 | 2003 | 1139 | 0.200 |
Why?
|
Heart Failure | 9 | 2024 | 10900 | 0.200 |
Why?
|
Creatinine | 6 | 2023 | 1919 | 0.190 |
Why?
|
United States | 24 | 2023 | 69872 | 0.190 |
Why?
|
Coronary Stenosis | 1 | 2007 | 834 | 0.190 |
Why?
|
Inflammation | 4 | 2016 | 10638 | 0.190 |
Why?
|
Xanthine Oxidase | 1 | 2020 | 64 | 0.180 |
Why?
|
Aspartate Aminotransferases | 1 | 2021 | 418 | 0.180 |
Why?
|
Adipokines | 1 | 2022 | 319 | 0.180 |
Why?
|
Cultural Diversity | 1 | 2023 | 359 | 0.180 |
Why?
|
Phosphodiesterase Inhibitors | 1 | 2001 | 215 | 0.180 |
Why?
|
Insulin Resistance | 1 | 2013 | 3864 | 0.170 |
Why?
|
Policy | 1 | 2023 | 508 | 0.170 |
Why?
|
Troponin T | 2 | 2014 | 754 | 0.170 |
Why?
|
Glomerulonephritis, Membranoproliferative | 1 | 1999 | 42 | 0.170 |
Why?
|
Alleles | 2 | 2023 | 6933 | 0.170 |
Why?
|
Alanine Transaminase | 1 | 2021 | 592 | 0.170 |
Why?
|
Regression Analysis | 4 | 2013 | 6459 | 0.160 |
Why?
|
Spin Labels | 1 | 2020 | 332 | 0.160 |
Why?
|
Sodium | 3 | 2022 | 1623 | 0.160 |
Why?
|
Cryoglobulinemia | 1 | 1999 | 87 | 0.160 |
Why?
|
Hyperlipidemias | 1 | 2003 | 789 | 0.160 |
Why?
|
Cardiomyopathies | 2 | 2024 | 1912 | 0.160 |
Why?
|
Financing, Government | 1 | 2021 | 468 | 0.150 |
Why?
|
Sleep Apnea, Obstructive | 1 | 2010 | 1813 | 0.150 |
Why?
|
Acute Kidney Injury | 2 | 2021 | 1972 | 0.150 |
Why?
|
Serine Endopeptidases | 1 | 2022 | 1072 | 0.150 |
Why?
|
Risk Adjustment | 1 | 2020 | 594 | 0.140 |
Why?
|
Research Personnel | 1 | 2021 | 573 | 0.140 |
Why?
|
Research Support as Topic | 1 | 2021 | 705 | 0.140 |
Why?
|
Thyroid Diseases | 1 | 2000 | 379 | 0.140 |
Why?
|
Adiponectin | 1 | 2022 | 1100 | 0.140 |
Why?
|
Proportional Hazards Models | 9 | 2021 | 12354 | 0.130 |
Why?
|
Obesity, Abdominal | 2 | 2016 | 361 | 0.130 |
Why?
|
Hematoma | 1 | 2020 | 758 | 0.130 |
Why?
|
Body Mass Index | 5 | 2016 | 12720 | 0.130 |
Why?
|
Metformin | 1 | 2022 | 835 | 0.130 |
Why?
|
Obesity | 4 | 2021 | 12745 | 0.130 |
Why?
|
Hypertrophy, Left Ventricular | 4 | 2015 | 859 | 0.130 |
Why?
|
Exercise | 1 | 2011 | 5615 | 0.130 |
Why?
|
Cause of Death | 4 | 2021 | 3584 | 0.130 |
Why?
|
Uromodulin | 1 | 2014 | 46 | 0.130 |
Why?
|
Health Status Disparities | 3 | 2021 | 1797 | 0.130 |
Why?
|
Cross-Sectional Studies | 10 | 2020 | 25043 | 0.130 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2010 | 3923 | 0.130 |
Why?
|
Tissue Donors | 2 | 2023 | 2240 | 0.130 |
Why?
|
N-Acetylgalactosaminyltransferases | 1 | 2014 | 65 | 0.120 |
Why?
|
Hypoglycemic Agents | 3 | 2022 | 2872 | 0.120 |
Why?
|
Natriuretic Peptide, Brain | 3 | 2024 | 1573 | 0.120 |
Why?
|
Hepacivirus | 1 | 2021 | 1379 | 0.120 |
Why?
|
Leptin | 1 | 2022 | 1599 | 0.120 |
Why?
|
Bicarbonates | 1 | 2015 | 313 | 0.120 |
Why?
|
Incidence | 7 | 2020 | 20947 | 0.120 |
Why?
|
Adiposity | 2 | 2014 | 1807 | 0.120 |
Why?
|
Diabetic Retinopathy | 1 | 2022 | 1210 | 0.110 |
Why?
|
Kidney Tubules | 1 | 2015 | 488 | 0.110 |
Why?
|
Patient Preference | 1 | 2020 | 890 | 0.110 |
Why?
|
Hepatitis C, Chronic | 1 | 2021 | 1031 | 0.110 |
Why?
|
Fibrinogen | 2 | 2014 | 894 | 0.110 |
Why?
|
Hypertension | 2 | 2010 | 8480 | 0.110 |
Why?
|
Single-Cell Analysis | 1 | 2023 | 2183 | 0.110 |
Why?
|
Markov Chains | 2 | 2017 | 969 | 0.110 |
Why?
|
Catheterization, Central Venous | 1 | 2017 | 514 | 0.110 |
Why?
|
Lymphoma, B-Cell | 1 | 1999 | 931 | 0.100 |
Why?
|
Hospitalization | 5 | 2020 | 10262 | 0.100 |
Why?
|
Young Adult | 15 | 2020 | 56430 | 0.100 |
Why?
|
Chromatin | 1 | 2024 | 2934 | 0.100 |
Why?
|
Apolipoproteins | 1 | 2013 | 317 | 0.100 |
Why?
|
Health Care Costs | 2 | 2017 | 3209 | 0.100 |
Why?
|
Potassium | 1 | 2015 | 1336 | 0.100 |
Why?
|
Proto-Oncogene Proteins | 2 | 2014 | 4554 | 0.100 |
Why?
|
Intra-Abdominal Fat | 1 | 2016 | 591 | 0.100 |
Why?
|
Osteoprotegerin | 1 | 2011 | 176 | 0.100 |
Why?
|
Polymorphism, Single Nucleotide | 6 | 2017 | 15519 | 0.090 |
Why?
|
Tomography, X-Ray Computed | 7 | 2017 | 20129 | 0.090 |
Why?
|
Waist-Hip Ratio | 1 | 2012 | 517 | 0.090 |
Why?
|
Pulsatile Flow | 1 | 2011 | 332 | 0.090 |
Why?
|
Immunosuppressive Agents | 3 | 2010 | 4149 | 0.090 |
Why?
|
Quality of Health Care | 2 | 2018 | 4371 | 0.090 |
Why?
|
Multivariate Analysis | 6 | 2016 | 12245 | 0.090 |
Why?
|
Piperazines | 1 | 2001 | 2488 | 0.090 |
Why?
|
Postoperative Complications | 3 | 2008 | 15295 | 0.090 |
Why?
|
Cadherins | 1 | 2014 | 907 | 0.090 |
Why?
|
Peptide Fragments | 3 | 2024 | 5097 | 0.090 |
Why?
|
Polycystic Kidney Diseases | 1 | 2010 | 133 | 0.090 |
Why?
|
Intraocular Pressure | 1 | 2015 | 1270 | 0.090 |
Why?
|
Quality-Adjusted Life Years | 2 | 2017 | 1683 | 0.090 |
Why?
|
Inflammation Mediators | 2 | 2016 | 1889 | 0.090 |
Why?
|
Ultrasonography, Doppler, Color | 1 | 2010 | 233 | 0.090 |
Why?
|
Pulse | 1 | 2009 | 229 | 0.090 |
Why?
|
Cataract | 1 | 2015 | 834 | 0.090 |
Why?
|
Acculturation | 1 | 2010 | 182 | 0.090 |
Why?
|
Enzyme Inhibitors | 1 | 2020 | 3798 | 0.090 |
Why?
|
Consensus | 3 | 2022 | 2959 | 0.080 |
Why?
|
Survival Analysis | 3 | 2018 | 10252 | 0.080 |
Why?
|
Lipoproteins, HDL | 1 | 2013 | 638 | 0.080 |
Why?
|
Risk Assessment | 8 | 2021 | 23338 | 0.080 |
Why?
|
Smoking | 3 | 2016 | 8987 | 0.080 |
Why?
|
Histocompatibility Testing | 2 | 2008 | 741 | 0.080 |
Why?
|
Membrane Proteins | 2 | 2022 | 7880 | 0.080 |
Why?
|
Graft Occlusion, Vascular | 1 | 2012 | 549 | 0.080 |
Why?
|
Chromosome Mapping | 1 | 2017 | 4740 | 0.080 |
Why?
|
Healthcare Disparities | 2 | 2021 | 3158 | 0.080 |
Why?
|
Health Expenditures | 1 | 2021 | 2348 | 0.080 |
Why?
|
Ankle Brachial Index | 2 | 2021 | 154 | 0.080 |
Why?
|
Sympathetic Nervous System | 1 | 2010 | 514 | 0.080 |
Why?
|
DNA Methylation | 1 | 2021 | 4286 | 0.080 |
Why?
|
Time Factors | 8 | 2018 | 40075 | 0.080 |
Why?
|
Comorbidity | 4 | 2017 | 10388 | 0.080 |
Why?
|
Genetic Loci | 1 | 2017 | 2575 | 0.080 |
Why?
|
Fatty Liver | 1 | 2013 | 727 | 0.070 |
Why?
|
Blood Vessel Prosthesis Implantation | 1 | 2017 | 1390 | 0.070 |
Why?
|
Gene Expression Profiling | 1 | 2023 | 9438 | 0.070 |
Why?
|
Quality of Life | 3 | 2021 | 12804 | 0.070 |
Why?
|
Hypolipidemic Agents | 2 | 2003 | 604 | 0.070 |
Why?
|
Morbidity | 1 | 2012 | 1769 | 0.070 |
Why?
|
Tacrolimus | 1 | 2010 | 743 | 0.070 |
Why?
|
Postmenopause | 1 | 2016 | 2461 | 0.070 |
Why?
|
Stroke | 3 | 2021 | 9981 | 0.070 |
Why?
|
Lipids | 2 | 2008 | 3305 | 0.070 |
Why?
|
Statistics as Topic | 1 | 2013 | 2373 | 0.070 |
Why?
|
Follow-Up Studies | 6 | 2014 | 39050 | 0.070 |
Why?
|
Vasodilation | 1 | 2010 | 944 | 0.070 |
Why?
|
HLA-A Antigens | 1 | 2007 | 231 | 0.070 |
Why?
|
Community-Institutional Relations | 1 | 2008 | 204 | 0.070 |
Why?
|
Drug Utilization | 1 | 2012 | 1183 | 0.070 |
Why?
|
Health Promotion | 1 | 2018 | 2205 | 0.070 |
Why?
|
Women's Health | 1 | 2016 | 2034 | 0.070 |
Why?
|
Odds Ratio | 4 | 2021 | 9849 | 0.070 |
Why?
|
Hemodynamics | 2 | 2020 | 4199 | 0.070 |
Why?
|
Treatment Failure | 2 | 2020 | 2618 | 0.070 |
Why?
|
Monitoring, Physiologic | 1 | 2013 | 1738 | 0.070 |
Why?
|
Biomedical Research | 1 | 2021 | 3309 | 0.070 |
Why?
|
HLA-B Antigens | 1 | 2007 | 353 | 0.070 |
Why?
|
Prognosis | 6 | 2016 | 29063 | 0.060 |
Why?
|
Pain | 1 | 2020 | 4986 | 0.060 |
Why?
|
Insulin | 1 | 2020 | 6580 | 0.060 |
Why?
|
Predictive Value of Tests | 4 | 2014 | 15076 | 0.060 |
Why?
|
Genetic Predisposition to Disease | 3 | 2016 | 17446 | 0.060 |
Why?
|
Triglycerides | 2 | 2014 | 2454 | 0.060 |
Why?
|
HLA-DR Antigens | 1 | 2007 | 645 | 0.060 |
Why?
|
Computational Biology | 1 | 2017 | 3521 | 0.060 |
Why?
|
Mycophenolic Acid | 1 | 2006 | 343 | 0.060 |
Why?
|
Genotype | 5 | 2022 | 12951 | 0.060 |
Why?
|
Genome-Wide Association Study | 7 | 2017 | 12261 | 0.060 |
Why?
|
Dyslipidemias | 1 | 2012 | 849 | 0.060 |
Why?
|
Fasting | 1 | 2010 | 1593 | 0.060 |
Why?
|
Magnetic Resonance Imaging, Cine | 1 | 2010 | 964 | 0.060 |
Why?
|
Sex Factors | 4 | 2021 | 10397 | 0.060 |
Why?
|
Calcium | 2 | 2014 | 5756 | 0.060 |
Why?
|
Sleep Deprivation | 1 | 2010 | 832 | 0.060 |
Why?
|
Cost-Benefit Analysis | 2 | 2017 | 5391 | 0.060 |
Why?
|
HLA Antigens | 1 | 2008 | 1381 | 0.060 |
Why?
|
Transplantation, Homologous | 2 | 2008 | 4776 | 0.060 |
Why?
|
Double-Blind Method | 3 | 2023 | 12026 | 0.050 |
Why?
|
Role | 1 | 2003 | 175 | 0.050 |
Why?
|
Angiopoietin-1 | 1 | 2022 | 114 | 0.050 |
Why?
|
Angiopoietins | 1 | 2022 | 80 | 0.050 |
Why?
|
Case-Control Studies | 4 | 2023 | 21746 | 0.050 |
Why?
|
Cathepsin D | 1 | 2022 | 61 | 0.050 |
Why?
|
Amino Acids | 1 | 2008 | 1736 | 0.050 |
Why?
|
Receptor, TIE-2 | 1 | 2022 | 178 | 0.050 |
Why?
|
Echocardiography | 2 | 2015 | 5102 | 0.050 |
Why?
|
Naphthyridines | 1 | 2022 | 118 | 0.050 |
Why?
|
Mortality | 3 | 2021 | 2864 | 0.050 |
Why?
|
Primary Health Care | 1 | 2018 | 4558 | 0.050 |
Why?
|
Energy Metabolism | 1 | 2013 | 2899 | 0.050 |
Why?
|
Guideline Adherence | 1 | 2012 | 2266 | 0.050 |
Why?
|
Vitamin K 1 | 1 | 2022 | 48 | 0.050 |
Why?
|
Reoperation | 1 | 2012 | 4201 | 0.050 |
Why?
|
Myocardium | 1 | 2015 | 4776 | 0.050 |
Why?
|
Iohexol | 1 | 2022 | 196 | 0.050 |
Why?
|
Angiopoietin-2 | 1 | 2022 | 173 | 0.050 |
Why?
|
Educational Status | 1 | 2010 | 2540 | 0.050 |
Why?
|
Longitudinal Studies | 4 | 2021 | 13989 | 0.050 |
Why?
|
Hemodialysis, Home | 1 | 2021 | 21 | 0.050 |
Why?
|
Logistic Models | 4 | 2021 | 13408 | 0.050 |
Why?
|
Treatment Refusal | 1 | 2005 | 421 | 0.050 |
Why?
|
Kidney Tubules, Proximal | 1 | 2024 | 416 | 0.050 |
Why?
|
Decision Support Techniques | 1 | 2012 | 1956 | 0.050 |
Why?
|
Radial Artery | 1 | 2003 | 194 | 0.050 |
Why?
|
Aged, 80 and over | 7 | 2024 | 57776 | 0.050 |
Why?
|
Coronary Angiography | 2 | 2018 | 4577 | 0.050 |
Why?
|
Survival Rate | 2 | 2013 | 12788 | 0.050 |
Why?
|
Health Education | 1 | 2008 | 1056 | 0.050 |
Why?
|
Hypertension, Renal | 1 | 2001 | 177 | 0.050 |
Why?
|
Age Factors | 3 | 2017 | 18370 | 0.050 |
Why?
|
Intermittent Claudication | 1 | 2003 | 309 | 0.050 |
Why?
|
Adolescent | 6 | 2020 | 85781 | 0.050 |
Why?
|
Glucose | 2 | 2022 | 4397 | 0.050 |
Why?
|
Vascular Patency | 1 | 2003 | 886 | 0.050 |
Why?
|
Phenotype | 1 | 2018 | 16365 | 0.050 |
Why?
|
Glucagon-Like Peptide 1 | 1 | 2022 | 340 | 0.050 |
Why?
|
Treatment Outcome | 5 | 2018 | 63114 | 0.050 |
Why?
|
Hemostasis, Surgical | 1 | 2020 | 128 | 0.050 |
Why?
|
Blood Glucose | 2 | 2014 | 6256 | 0.050 |
Why?
|
Interferon Regulatory Factors | 1 | 2021 | 270 | 0.050 |
Why?
|
Life Style | 1 | 2011 | 3835 | 0.040 |
Why?
|
Gene Frequency | 2 | 2017 | 3588 | 0.040 |
Why?
|
Nutrition Surveys | 2 | 2018 | 1660 | 0.040 |
Why?
|
Health Facilities | 1 | 2005 | 573 | 0.040 |
Why?
|
Patient Discharge | 1 | 2012 | 3313 | 0.040 |
Why?
|
Albumins | 1 | 2022 | 569 | 0.040 |
Why?
|
Vitamin K | 1 | 2022 | 295 | 0.040 |
Why?
|
Cell Count | 1 | 2024 | 1856 | 0.040 |
Why?
|
Protective Agents | 1 | 2020 | 156 | 0.040 |
Why?
|
Medicare | 2 | 2021 | 6566 | 0.040 |
Why?
|
Heart Diseases | 1 | 2012 | 2788 | 0.040 |
Why?
|
Risk | 1 | 2011 | 9687 | 0.040 |
Why?
|
Hematuria | 1 | 2020 | 235 | 0.040 |
Why?
|
Glomerular Mesangium | 1 | 1999 | 108 | 0.040 |
Why?
|
Medicaid | 1 | 2012 | 2736 | 0.040 |
Why?
|
Hospital Mortality | 1 | 2012 | 5317 | 0.040 |
Why?
|
Proteomics | 2 | 2022 | 3638 | 0.040 |
Why?
|
Parathyroid Hormone | 2 | 2017 | 1801 | 0.040 |
Why?
|
Linear Models | 3 | 2014 | 5952 | 0.040 |
Why?
|
Sulfones | 1 | 2001 | 437 | 0.040 |
Why?
|
Endothelium, Vascular | 1 | 2010 | 4456 | 0.040 |
Why?
|
Polymorphism, Genetic | 1 | 2008 | 4328 | 0.040 |
Why?
|
Public Health | 2 | 2021 | 2603 | 0.040 |
Why?
|
Models, Biological | 1 | 2014 | 9583 | 0.040 |
Why?
|
CpG Islands | 1 | 2021 | 1172 | 0.040 |
Why?
|
Education | 1 | 2020 | 543 | 0.040 |
Why?
|
Purines | 1 | 2001 | 594 | 0.040 |
Why?
|
Anemia | 1 | 2006 | 1506 | 0.040 |
Why?
|
Chi-Square Distribution | 2 | 2015 | 3508 | 0.040 |
Why?
|
Mood Disorders | 1 | 2003 | 1106 | 0.040 |
Why?
|
Cathepsin C | 1 | 2015 | 2 | 0.030 |
Why?
|
Ultrasonography | 1 | 2009 | 5985 | 0.030 |
Why?
|
Cuba | 1 | 2015 | 47 | 0.030 |
Why?
|
Central America | 1 | 2015 | 68 | 0.030 |
Why?
|
Dominican Republic | 1 | 2015 | 76 | 0.030 |
Why?
|
Europe | 1 | 2022 | 3339 | 0.030 |
Why?
|
Interpersonal Relations | 1 | 2003 | 1425 | 0.030 |
Why?
|
Urinalysis | 1 | 2018 | 369 | 0.030 |
Why?
|
Cultural Competency | 1 | 2018 | 289 | 0.030 |
Why?
|
South America | 1 | 2015 | 181 | 0.030 |
Why?
|
Communication Barriers | 1 | 2018 | 398 | 0.030 |
Why?
|
Practice Guidelines as Topic | 1 | 2012 | 7279 | 0.030 |
Why?
|
Informed Consent | 1 | 2021 | 995 | 0.030 |
Why?
|
Sulfotransferases | 1 | 2015 | 151 | 0.030 |
Why?
|
Up-Regulation | 2 | 2016 | 4217 | 0.030 |
Why?
|
Hypercalcemia | 1 | 2017 | 409 | 0.030 |
Why?
|
Mississippi | 1 | 2014 | 88 | 0.030 |
Why?
|
Puerto Rico | 1 | 2015 | 356 | 0.030 |
Why?
|
Cell Nucleus | 1 | 2023 | 2969 | 0.030 |
Why?
|
Trust | 1 | 2018 | 505 | 0.030 |
Why?
|
Socioeconomic Factors | 2 | 2021 | 7785 | 0.030 |
Why?
|
rab GTP-Binding Proteins | 1 | 2015 | 246 | 0.030 |
Why?
|
Blood Transfusion | 1 | 2020 | 1301 | 0.030 |
Why?
|
Delayed Graft Function | 1 | 2014 | 48 | 0.030 |
Why?
|
Biopsy, Needle | 1 | 1999 | 1641 | 0.030 |
Why?
|
Mexico | 1 | 2015 | 690 | 0.030 |
Why?
|
Indians, North American | 1 | 2017 | 355 | 0.030 |
Why?
|
Health Surveys | 1 | 2003 | 4037 | 0.030 |
Why?
|
Magnetic Resonance Imaging | 1 | 2020 | 35421 | 0.030 |
Why?
|
Models, Economic | 1 | 2017 | 713 | 0.030 |
Why?
|
Genome, Human | 2 | 2017 | 4420 | 0.030 |
Why?
|
Gene Knockout Techniques | 1 | 2015 | 809 | 0.030 |
Why?
|
Interleukin 1 Receptor Antagonist Protein | 1 | 2014 | 297 | 0.030 |
Why?
|
Diuretics | 1 | 2015 | 592 | 0.030 |
Why?
|
Monte Carlo Method | 1 | 2017 | 1254 | 0.030 |
Why?
|
Research | 1 | 2020 | 1999 | 0.030 |
Why?
|
Animals | 5 | 2022 | 168757 | 0.030 |
Why?
|
Hospital Bed Capacity | 1 | 2012 | 214 | 0.020 |
Why?
|
Emotions | 1 | 2003 | 2661 | 0.020 |
Why?
|
Receptors, Fibroblast Growth Factor | 1 | 2011 | 185 | 0.020 |
Why?
|
Serum Albumin | 1 | 2014 | 676 | 0.020 |
Why?
|
Life Expectancy | 1 | 2017 | 1184 | 0.020 |
Why?
|
Health Status | 1 | 2024 | 4034 | 0.020 |
Why?
|
Glucuronidase | 1 | 2011 | 207 | 0.020 |
Why?
|
Absorptiometry, Photon | 1 | 2016 | 1725 | 0.020 |
Why?
|
Carotid Artery, Common | 1 | 2010 | 183 | 0.020 |
Why?
|
Electric Impedance | 1 | 2014 | 729 | 0.020 |
Why?
|
Endothelial Cells | 1 | 2022 | 3479 | 0.020 |
Why?
|
Imaging, Three-Dimensional | 1 | 2023 | 4042 | 0.020 |
Why?
|
Myocardial Contraction | 1 | 2015 | 1585 | 0.020 |
Why?
|
Living Donors | 1 | 2014 | 620 | 0.020 |
Why?
|
Glucocorticoids | 1 | 1999 | 2107 | 0.020 |
Why?
|
Fibroblast Growth Factor 2 | 1 | 2011 | 599 | 0.020 |
Why?
|
Diabetes Mellitus, Experimental | 1 | 2015 | 1116 | 0.020 |
Why?
|
Antiviral Agents | 1 | 2021 | 2987 | 0.020 |
Why?
|
Language | 1 | 2018 | 1471 | 0.020 |
Why?
|
Societies, Medical | 1 | 2021 | 3743 | 0.020 |
Why?
|
Mental Health | 1 | 2003 | 3019 | 0.020 |
Why?
|
Myocardial Revascularization | 1 | 2012 | 841 | 0.020 |
Why?
|
Hepatitis C | 1 | 1999 | 1591 | 0.020 |
Why?
|
Phosphates | 1 | 2012 | 786 | 0.020 |
Why?
|
Interleukin-10 | 1 | 2014 | 1200 | 0.020 |
Why?
|
Interleukin-1beta | 1 | 2014 | 972 | 0.020 |
Why?
|
Regional Blood Flow | 1 | 2011 | 1525 | 0.020 |
Why?
|
Combined Modality Therapy | 1 | 2000 | 8642 | 0.020 |
Why?
|
Histocompatibility | 1 | 2008 | 330 | 0.020 |
Why?
|
Rats | 2 | 2015 | 24260 | 0.020 |
Why?
|
Receptor, Angiotensin, Type 1 | 1 | 2007 | 152 | 0.020 |
Why?
|
Pilot Projects | 1 | 2020 | 8324 | 0.020 |
Why?
|
Pennsylvania | 1 | 2007 | 613 | 0.020 |
Why?
|
Models, Cardiovascular | 1 | 2011 | 996 | 0.020 |
Why?
|
Receptors, Cell Surface | 1 | 2015 | 2866 | 0.020 |
Why?
|
Transforming Growth Factor beta | 1 | 2014 | 2007 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2016 | 6538 | 0.020 |
Why?
|
Tibia | 1 | 2011 | 1077 | 0.020 |
Why?
|
Physician-Patient Relations | 1 | 2018 | 3229 | 0.020 |
Why?
|
Signal Transduction | 2 | 2022 | 23403 | 0.020 |
Why?
|
Patient Selection | 1 | 2017 | 4215 | 0.020 |
Why?
|
Cognition | 1 | 2022 | 6770 | 0.020 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2011 | 3870 | 0.010 |
Why?
|
Ventricular Dysfunction, Left | 1 | 2015 | 2073 | 0.010 |
Why?
|
Reproducibility of Results | 2 | 2013 | 19905 | 0.010 |
Why?
|
Health Services Accessibility | 1 | 2021 | 5137 | 0.010 |
Why?
|
Poverty | 1 | 2015 | 2660 | 0.010 |
Why?
|
Depression | 1 | 2003 | 7766 | 0.010 |
Why?
|
Computer Simulation | 1 | 2017 | 6196 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 1999 | 12959 | 0.010 |
Why?
|
Drug Prescriptions | 1 | 2012 | 1637 | 0.010 |
Why?
|
Myocytes, Cardiac | 1 | 2011 | 1637 | 0.010 |
Why?
|
Cadaver | 1 | 2007 | 1337 | 0.010 |
Why?
|
Analysis of Variance | 1 | 2011 | 6365 | 0.010 |
Why?
|
Ventricular Function, Left | 1 | 2015 | 3670 | 0.010 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2014 | 4420 | 0.010 |
Why?
|
Amino Acid Substitution | 1 | 2007 | 1791 | 0.010 |
Why?
|
Transcription Factors | 1 | 2021 | 12208 | 0.010 |
Why?
|
Recombinant Proteins | 1 | 2011 | 6622 | 0.010 |
Why?
|
Mice | 2 | 2022 | 81183 | 0.010 |
Why?
|
Stroke Volume | 1 | 2012 | 5007 | 0.010 |
Why?
|
Retrospective Studies | 3 | 2014 | 77449 | 0.010 |
Why?
|
Bone Density | 1 | 2011 | 3468 | 0.010 |
Why?
|
Epidemiologic Methods | 1 | 2003 | 1364 | 0.010 |
Why?
|
Heart Ventricles | 1 | 2010 | 3821 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2013 | 14722 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2016 | 12072 | 0.010 |
Why?
|
Registries | 1 | 2012 | 8089 | 0.010 |
Why?
|
Drug Administration Schedule | 1 | 2005 | 4933 | 0.010 |
Why?
|
Chronic Disease | 1 | 2011 | 9146 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2011 | 14557 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2013 | 15540 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2011 | 21827 | 0.010 |
Why?
|
DNA | 1 | 2007 | 7301 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2011 | 18029 | 0.010 |
Why?
|
Graft Rejection | 1 | 2005 | 4397 | 0.010 |
Why?
|